EXPERIENCE OF APPLICATION OF THE FIRST REPRESENTATIVE OF CLASS ARNI (ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR) SACUBITRIL/VALSARTAN IN PATIENTS WITH CARDIOPULMONIAL PATHOLOGY - PDF (Russian)
Copyright (c) 2019 Kalimulin O.A., Rudchenko I.V., Koltsov A.V., Shcherbatyuk O.V., Bologov S.G., Kachnov V.A.
![Creative Commons License](http://licensebuttons.net/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
![](https://kazanmedjournal.ru/files/journals/10/misc/interface/16.gif)
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77760 от 10.02.2020.